Denver Post
Cancer survivors infected with COVID-19 in the early months of the pandemic had a higher risk of dying from dormant cells reawakening, Colorado researchers found, though they don’t know whether people who get the virus now face the same risk.
Experiments in mice found that genetically modified animals were more likely to have signs of metastatic cancer in their lungs if infected with flu or COVID-19 than engineered mice that researchers didn’t give a virus, said James DeGregori, deputy director of the University of Colorado Cancer Center in Aurora.
That finding launched an international partnership to determine whether the same thing happened in people, he said.
DeGregori was one of the lead investigators, alongside scientists from Utrecht University in the Netherlands, Imperial College London, University College London, University of Connecticut, Albert Einstein College of Medicine in New York City, Children’s Hospital of Philadelphia, and the COVID-19 International Research Team, based in Massachusetts.
Two datasets, from the United States and the United Kingdom, both showed a higher risk that cancer survivors with confirmed COVID-19 infections would die from metastatic cancer, compared to survivors who didn’t test positive for the virus.